TNGNQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TNGNQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Tengion's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2014 was 0.00%.
Tengion's Revenue per Share for the three months ended in Sep. 2014 was $0.00.
The historical data trend for Tengion's YoY Rev. per Sh. Growth can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tengion Annual Data | ||||||||||||||||
Trend | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | |||||||||
YoY Rev. per Sh. Growth | Get a 7-Day Free Trial | - | - | - | - | - |
Tengion Quarterly Data | ||||||||||||||||||||
Dec09 | Mar10 | Jun10 | Sep10 | Dec10 | Mar11 | Jun11 | Sep11 | Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | |
YoY Rev. per Sh. Growth | Get a 7-Day Free Trial | - | - | - | - | - |
YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.
Tengion's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2013 is calculated as:
YoY Rev. per Sh. Growth (A: Dec. 2013 ) | |||||
= | (Revenue per Share (A: Dec. 2013 ) | - | Revenue per Share (A: Dec. 2012 )) | / | | Revenue per Share (A: Dec. 2012 ) | |
= | (0 | - | 0) | / | | 0 | |
= | N/A % |
Tengion's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2014 is calculated as:
YoY Rev. per Sh. Growth (Q: Sep. 2014 ) | |||||
= | (Revenue per Share (Q: Sep. 2014 ) | - | Revenue per Share (Q: Sep. 2013 )) | / | | Revenue per Share (Q: Sep. 2013 )) | |
= | (0 | - | 0) | / | | 0 | |
= | N/A % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Tengion's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.
John L Miclot | director, officer: President and CEO | 5005 OLD ORCHARD LANE, GIBSONIA PA 15044 |
Lorin Randall | director | C/O ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502 |
A Brian Davis | officer: Chf. Fin. Offr, VP Fin. | C/O VERRICA PHARMACEUTICALS INC., 10 NORTH HIGH STREET, SUITE 200, WEST CHESTER PA 19380 |
Medtronic Inc | 10 percent owner | 710 MEDTRONIC PKWY, MINNEAPOLIS MN 55432 |
Johan Christenson | 10 percent owner | C/O ODLANDER, FREDRIKSON & CO. AB, STRANDVAGEN 5B, STOCKHOLM V7 SE-114 51 |
Staffan Lindstrand | 10 percent owner | C/O ODLANDER, FREDRIKSON & CO. AB, STRANDVAGEN 5B, STOCKHOLM V7 SE-114 51 |
Richard Kuntz | director | MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432 |
Diane Jorkasky | director | 60 MANOR AVENUE, WELLESLEY MA 02482 |
Mark Stejbach | officer: VP and Chief Commercial Offcr | C/O TENGION, INC., 2900 POTSHOP LANE, SUITE 100, EAST NORRITON PA 19403 |
Steven Nichtberger | director, officer: President and CEO | C/O CABALETTA BIO, INC., 2929 ARCH STREET, SUITE 600, PHILADELPHIA PA 19104 |
Johnson & Johnson | 10 percent owner | ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ 08933 |
Johnson & Johnson Innovation - Jjdc, Inc. | 10 percent owner | 410 GEORGE STREET, NEW BRUNSWICK NJ 08901 |
Oak Investment Partners Xi L P | 10 percent owner | 901 MAIN AVENUE, SUITE 600, NORWALK CT 06851 |
From GuruFocus
By gurufocus 10qk • 05-20-2010
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.